Zobrazeno 1 - 10
of 55
pro vyhledávání: '"F.W. Peyerl"'
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 7, p e0235040 (2020)
PLoS ONE, Vol 15, Iss 7, p e0235040 (2020)
The objective of this analysis was to evaluate and report on the economic impact of implementing an integrated, quality, and operational improvement program on chronic obstructive pulmonary disease (COPD) care from acute through post-acute care setti
Publikováno v:
Open Access Rheumatology : Research and Reviews
Victor Khangulov,1 Xuan Zhang,1 Sibyl H Munson,1 Fred Peyerl,1 Francoise Rey2 1Department of Health Economics and Outcomes Research, Boston Strategic Partners, Inc., Boston, MA, USA; 2Sanofi, Paris, FranceCorrespondence: Victor Khangulov 15 Graham St
Autor:
VS Khangulov, F.W. Peyerl, AJ Ravindranath, Suzanne Laplante, Carol R. Schermer, D Makhija, Sibyl H. Munson, Scott M. Paluszkiewicz
Publikováno v:
PharmacoEconomics Open
Background There is growing evidence of the benefits of intravenous fluid therapy with balanced crystalloids over 0.9% ‘normal’ saline. This analysis evaluated the economic impact of increasing usage of a calcium-free balanced crystalloid solutio
Publikováno v:
Value in Health. 20:379-387
Background Although evidence suggests significant clinical benefits of home noninvasive ventilation (NIV) for management of severe chronic obstructive pulmonary disease (COPD), economic analyses supporting the use of this technology are lacking. Obje
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249844 (2021)
[This corrects the article DOI: 10.1371/journal.pone.0235040.].
Publikováno v:
Value in Health. 21:S68-S69
Publikováno v:
Value in Health. 22:S247
Autor:
M. Shen, L. Gannu, A. Shenoy, F. D'Souza, F.W. Peyerl, D.K. Hayashida, G.V. Varsos, K. Lodaya
Publikováno v:
Value in Health. 22:S189
Publikováno v:
Value in Health. 22:S357
Autor:
F.W. Peyerl, A. Shenoy, L. Gannu, D.K. Hayashida, F. D'Souza, G.V. Varsos, K. Lodaya, M. Shen
Publikováno v:
Value in Health. 22:S378